CGV控股與IMAX擴展合作在內地新建40家影院
影院品牌CGV控股與IMAX,IMAX China(01970.HK)宣布,計劃進一步擴展雙方合作,在中國新簽40家IMAX影院。加上新簽約影院,CGV目前在中國、越南和南韓等地開業及簽約待建的IMAX影院總數超過170家。
這些新簽IMAX影院將主打突破性的IMAX with Laser放映系統。根據協定,CGV和IMAX在內地一、二線市場計劃新開設的影院主要為收入分成模式,在三到五線市場新開設的影院將為IMAX無淨資產承諾的混合分成模式。其他條款並未披露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.